To assess the adrenal function, rapid-ACTH stimulation test has been widely used, which involves measurement of serum cortisol after intravenous injection of 250 µg α 1-24 corticotropin acetate [1, 2] . In our institute, we routinely perform rapid-ACTH stimulation test with low and high dose dexamethasone (DEX) suppression to assess the response to exogenous ACTH [3, 4] . However, we have little knowledge about the changes of urinary free cortisol (FF) and cortisone (FE) concentration under this setting.
able methods to measure urinary free glucocorticoids, and give insight into the response of FF and FE to exogenous ACTH under suppression of endogenous ACTH by examining the changes of FF and FE as well as FF/FE ratio in pooled urine after rapid-ACTH stimulation test under DEX suppression using stable isotope dilution -gas chromatography mass spectrometry (SID-GC/MS). First, we validated the method to measure free glucocorticoid in urine using double derivatization of bismethylenedioxy-heptafluorobutylate and SID-GC/MS [5, 6] . Second, we measured FF and FE in pooled urine after rapid-ACTH stimulation test under DEX suppression and calculated FF/ FE ratio. ally collected from 2300 h on day 1 for 72 hours. Each pooled urine was designated as Basal, DEX1mg, and DEX8mg-ACTH, respectively. All urine was stored at -20°C until assay.
Subjects
To validate the SID-GC/MS method, twenty four hour pooled urine was collected from 5 adult volunteers and mixed. We added DEX to the mixed urine.
From February 2008 to June 2008, we performed rapid-ACTH stimulation test under DEX suppression in 15 patients who had adrenal incidentaloma and were suspected to have primary aldosteronism. We recruited 8 patients out of 15 in this study whose glucocorticoid secretion was proven to be normal judging from 1) < 3 mg/dL serum cortisol after 1mg DEX suppression and 2) >15 mg/dL serum cortisol 60 min after ACTH stimulation [4] . Diagnosis of primary aldosteronism (PA) was based on The Endocrine Society clinical practice guideline [7] and The Japan Endocrine Society guideline [8] . The distinction between aldosterone-producing adenoma and idiopathic hyperaldosteronism were made by adrenal venous sampling (AVS). PA without AVS were defined as PA (laterality unknown). The etiology of secondary aldosteronism in patient no. 5 was unknown. The patients' characteristics are shown in Table 1 .
This study was approved by the institutional ethical committee, and all patients gave written informed consent.
Plasma ACTH and serum cortisol measurement
We measured plasma ACTH and serum cortisol
Materials and Methods

Chemicals and reagents
Cortisol, cortisone, and dexamethasone were purchased from Sigma-Aldorich (St. Louis, MO, U.S.A.) [9, 11, 12, 12-d4 ]-cortisol (d4F) was purchased from C/D/N Isotopes (Quebec, Canada). [9, 12, 12-d3 ]-cortisone (d3E) was synthesized at Chemical Soft R & D Inc. (Kyoto, Japan) using [9, 12, 12-d3 ]-cortisol purchased at Cambridge Isotope Laboratories Inc. (Andover, MA, U.S.A.). Heptafluoro-n-butyric anhydride was obtained from GL Science (Tokyo, Japan). Ethyl acetate, paraformaldehyde, hydrochloric acid, dichloromethane, toluene, cyclohexane, and ethanol were all analytical reagent grade. Toluene and cyclohexane were dehydrated by molecular sieves 4A 1/8 (Wako. Osaka, Japan). Bismethylenedioxy-derivative reagent was freshly prepared by dissolving a mixture of paraformaldehyde (1.66 g), concentrated hydrochloric acid (7.1 mL), and purified water (2.9 mL) using ultrasonic.
Rapid-ACTH stimulation test with DEX suppression
We performed rapid-ACTH stimulation test with DEX suppression for consecutive 4 days according to Okabe et al. [4] (Fig. 1). (1) DEX suppression: 1 mg DEX was given orally at 2300 h on day 2, then 8 mg at 2300 h on day 3. (2) Rapid-ACTH stimulation: 250 µg of α 1-24 corticotropin acetate was given intravenously at 0900 h on day 4. (3) Blood sample was obtained at 0700 h on day 3, 0700 h on day 4, and 1000 h on day 4, respectively, to measure plasma ACTH and serum cortisol. (4) Twenty four hour urine samples were seri- by ECLusys ACTH (Roche Diagnostics, Mannheim, Germany) and ST AIA-PACK CORT (TOSOH, Tokyo, Japan), respectively. The analysis was performed according to the instruction manuals for each kit.
SID-GC/MS selected ion monitoring (SIM) analysis
Sample preparations to analyze free steroids were as follows [5, 6 ]: 1. Two internal standards were added to 1 mL of urine or mixed standard solution. 2. Free steroids were extracted by 2 mL of ethyl acetate. 3. The mixture was evaporated at room temperature under nitrogen gas. 4. The residue was dissolved in 100 μL of dichloromethane. 5. The mixture was added to 100 μL of bismethylenedioxy-derivative reagent and incubated for 20 min at room temperature. 6. The mixture was added to 1.5 mL of dichloromethane and washed with 1 mL of water three times. 7. The mixture was evaporated at room temperature under nitrogen gas. 8. The residue was dissolved in 100 μL dehydrated toluene. 9. The mixture was added to 25 μL of heptafluoro-n-butyric anhydride and incubated for 30 min at 50°C. 10. The mixture was evaporated at 50°C under nitrogen gas. 11. The residue was dissolved in 20 μL of dehydrated cyclohexane. 12. Four μL of the solution was analyzed using GC/MS. GC/MS analysis was performed on a HP5890II GC with a HP-ULTRA1 fused silica column (25 m × 0.2 mm, d f 0.33μm, Agilent Technologies, Palo Alto, CA, U.S.A.) coupled to a HP5971 MS (Agilent Technologies). Helium was used as carrier gas at a flow rate of 1 mL/min. The injections took place with a 100°C (2 min) GC oven. The temperature was then increased by 30°C /min to 230°C which was maintained for 2 min. Then, the temperature was increased by 12°C /min to 290°C which was maintained for 20 min. SIM analysis were performed with two characteristic mass ions selected for each steroid (FF; m/z 600, 508, m/z FE; 598, 507, DEX; m/z 630, 317, d4F; m/z 605, 513, d3E; m/z 603, 510). The ratio of first ion peak area of each steroid to that of d4F (for FF) or d3E (for FE and DEX) was used for quantification. The calibration curve was constructed by six mixed standard solutions (1, 5, 10, 20, 50, 100 ng/mL).
Total urinary cortisol metabolites (ΣF) were analyzed by the steroid profile analysis according to methods previously reported by Homma et al. [9] . ΣF contains cortisol (F), 6β-hydroxycortisol, 5α-and 5β-tetrahydrocortisol (THF), 20α-and 20β-cortol, 20α-and 20β-dihydrocortisol, cortisone (E), 5α-and 5β-tetrahydrocortisone (THE), 20α-and 20β-cortolone, 5α20β-cortolone, 20α-and 20β-dihydrocortisone.
Statistical analysis
Statistical analysis was carried out by Wilcoxon signed rank sum test. We used Hochberg-Benjamini's false discovery rate controlling procedure to adjust for multiple testing (q=0.05) [10] .
Results
Validation of the free gulcocorticoids method
The interassay coefficient variation (C. V.) (n=10) for FF, FE, and DEX in pooled urine was 6, 2, and 9%, respectively. The intraassay C. V. (n=5) in pooled urine was 8, 2, and 7%, respectively. The recovery rates from tion increased free type cortisol rather than total cortisol in blood. Vogeser et al. reported that serum free/ total ratio of cortisol increased after ACTH stimulation [14] , which was identical to ours.
This study had, however, some limitations. First, we did not separate urines before and after rapid-ACTH stimulation, and DEX8mg-ACTH contained before and after. Nonetheless, we believe the comparison of FF and FE in DEX8mg-ACTH with those DEX1mg was possible because cortisol secretion by rapid-ACTH stimulation were reported to last 4 hours [17] . The main conclusion of this study must be the same. Second, subjects of this study included patients with primary aldosteronism, secondary aldosteronism, and non-functional tumor. However, we believe that the conclusion of this study can be applied to healthy adult because all of the patients were proven to have normal glucocoruticoid secretion by rapid-ACTH test and DEX suppression. Third, there was individual variation of urinary DEX concentration (Table 2) . Individual variation of DEX glucuronidation and/or metabolism must be probable. As far as we know, individual variation of those has not been reported. Forth, we did not measure urinary free 11-deoxycortisol in this study. Eleven-β-hydroxylase is reported to be sensitive to changes in HPA axis dynamics. Further study is needed to evaluate the influence of this enzyme activity to FF and FE concentration.
In conclusion, we validated a reliable method of simultaneous measuring free glucocorticoids, namely F, E, and DEX. Our method might be useful to evaluate F-E conversion with DEX metabolism e.g. in DEX suppression test in Cushing and sub-clinical Cushing syndrome. Using this method, we demonstrated that FF/FE ratio was increased after rapid-ACTH test stimulation under DEX suppression. These data suggest that urine were 85-102, 96-101, 91-97%, respectively. The linearity was observed from 0 to 90, 0 to 40, and 0 to 170 ng/tube (ng/mL in urine). The sensitivity was 0.3, 0.5, 5 ng/tube (ng/mL in urine), respectively.
FF, FE, DEX, and ΣF in urine by rapid-ACTH stimulation test under DEX suppression
The results were summarized in Table 2 . FF, FE, DEX and ΣF were significantly increased from DEX1mg to DEX8mg-ACTH. It was of note that DEX concentration in DEX8mg-ACTH was 8 times or more higher compared with that in DEX1mg. The FF levels in DEX8mg-ACTH showed no significant difference to Basal. On the other hand, The FE and ΣF levels in DEX8mg-ACTH were significantly lower than Basal.
FF/FE ratio and FF/ΣF ratio in urine by rapid-ACTH stimulation test under DEX suppression
The results were summarized in Table 2 . FF/FE ratio was not different between Basal and DEX1mg. However, this ratio in DEX8mg-ACTH was significantly increased from Basal and DEX1mg. Similarly, FF/ΣF ratio was significantly increased in DEX8mg-ACTH from DEX1mg.
Discussion
In this study, we established and validated GC/MS method of simultaneous measuring free glucocorticoids and demonstrated good precision and sensitivity. Since non-immunochemical SID-GC/MS does not have interference with cross-reactivity of antibodies, presented method is theoretically more specific than immunochemical measurement of urinary steroids [11, 12] .
We think newly synthesized cortisol by ACTH stimulation cannot be efficiently metabolized to cortisone, judging from increase in FF/FE ratio from DEX1mg to DEX8mg-ACTH. In the literature, increase in cortisol/cortisone ratio has been reported in blood [13, 14] or urine metabolites [15] after ACTH stimulation test, which also suggested the activity of key enzyme, type 2 11β-hydroxysteroid dehydrogenase, cannot be adjusted to increased cortisol. Moreover, Morita et al. reported increased plasma cortisol/cortisone ratio in Cushing disease [16] . This means that chronically oversynthesized cortisol were also not metabolized to cortisone efficiently.
The increase in FF/ΣF ratio in urine after rapid-ACTH stimulation was indicated that ACTH stimula- acutely oversynthesized cortisol cannot be efficiently metabolized to cortisone. We believe these findings are valuable to understand the role of the renal activity of type 2 11β-hydroxysteroid dehydrogenase in response to changes in HPA axis dynamics.
